SCHEMBL6660205

SCHEMBL6660205

C=CCCOC#N

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL98184 0.72
SCHEMBL582903 0.72
SCHEMBL8763968 0.71
SCHEMBL644334 0.71
SCHEMBL19197245 0.69
SCHEMBL18672372 0.69
SCHEMBL9544266 0.69
SCHEMBL6760052 0.67
SCHEMBL6594058 0.67
SCHEMBL21539529 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1145716-B1 Therapeutic agent for the treatment of dermatitis NIPPON ZOKI PHARMACEUTICAL CO (JP) 2004-08-04 EP disclosed
US-6440978-B2 A THERAPEUTICAL AGENT FOR DERMATITIS COMPRISES 7-AMINO-3-(HALO SUBSTITUTED OR UNSUBSTITUED BENZYL)-1,2,3-TETRAHYDRO-1-PHENYLPYRIDO(2,3-D)PYRIMIDIN-2,4-DIONE NIPPON ZOKI PHARMACEUTICAL CO., LTD. (JP) 2002-08-27 US disclosed
US-20010056097-A1 Therapeutic agent for dermatitis NIPPON ZOKI PHARMACEUTICAL CO., LTD. (JP) 2001-12-27 US disclosed
EP-1145716-A2 Therapeutic agent for the treatment of dermatitis NIPPON ZOKI PHARMACEUTICAL CO., LTD. (JP) 2001-10-17 EP disclosed